BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 119699)

  • 1. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A portable, pre-programmable insulin infusion system in diabetes mellitus.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J; Selam JL; Pham TC; Orsetti A
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
    Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic control with a portable insulin infusion pump for 7 weeks (author's transl)].
    Irsigler K; Kritz H; Koller W; Kaspar L; Mader R; Franetzki M
    Med Klin; 1978 Dec; 73(49):1738-43. PubMed ID: 723761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin infusion pumps in the treatment of diabetes.
    Blackshear PJ
    Med Instrum; 1982; 16(1):17-9. PubMed ID: 7038411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
    Ratzmann KP; Jutzi E; Albrecht G
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
    Talaulicar M; Willms B
    Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin portable pump vs. intensified conventional injections in diabetes].
    Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
    Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.